| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16 |
| filingDate |
1999-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca5da4b14ec60255fb4435bea392c4a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b61784a6882d3e50be32c5cda9f84a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de697a8c8ed99db504df194785e85bb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d91568659b03445cbe905ba043b068fe |
| publicationDate |
2001-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2001072605-A |
| titleOfInvention |
Percutaneous transmucosal absorption enhancer composition |
| abstract |
(57) [Problem] To provide a composition capable of effectively absorbing a physiologically active substance through skin and mucous membranes and providing a sufficient pharmacological effect. The composition comprises a transdermal transmucosal absorption promoter comprising an N-substituted-p-menthan-3-carboxamide derivative or a transdermal transmucosal absorption-promoting composition in combination with a physiologically active substance. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10150729-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9822066-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015516951-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004112735-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010083823-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005533076-A |
| priorityDate |
1999-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |